Sugammadex Fresenius i.v. 200 mg/2 ml, Injektionslösung
7680697030011
CH-69703
Injektionslösung
Associated product:
SUGAMMADEX Fresenius 200 mg/2ml flac 10 pce
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
sugammadexum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
sugammadexum natricum
|
- | Substance | WIZUS |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
19.4 MG | Substance | HBESI |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 69703
- Drug name
- Sugammadex Fresenius i.v., Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- V03AB35
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 15/11/2024
- Authorization expiration date
- 14/11/2029
- IT Number
- 15.01.0.
- Domain
- Human medicine
Package details
- Description (FR)
- SUGAMMADEX Fresenius 200 mg/2ml flac 10 pce
- Description (DE)
- SUGAMMADEX Fresenius 200 mg/2ml Durchstf 10 Stk
- Market launch
- 15/11/2024
- Narcotic (BTM)
- No
Other package sizes (1)
SUGAMMADEX Fresenius 500 mg/5ml flac 10 pce
10 DUR
GTIN: 7680697030028